Epstein-Barr virus-associated post-transplant smooth muscle tumours in a kidney transplant patient-Reference-Cited by-同舟云学术

Epstein-Barr virus-associated post-transplant smooth muscle tumours in a kidney transplant patient

Published:2024-09-04 Issue: Volume: Page:
ISSN:0931-041X
Container-title:Pediatric Nephrology
language:en
Short-container-title:Pediatr Nephrol

Author:

Cobeñas Carlos J.^ORCID,Pereyra Priscila,Spizzirri Ana Paula,Gauto Santacruz Cristina,del Carmen Suarez Angela,Altamirano Eugenia,Pérez Paula,Tello Nicolas

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00467-024-06493-4.pdf

Reference5 articles.

1. Mocellin S (2021) EBV-associated smooth muscle tumor. In: Soft tissue tumors. Springer, Cham. https://doi.org/10.1007/978-3-030-58710-9_75

2. Hussein K, Maecker-Kolhoff B, Donnerstag F, Laenger F, Kreipe H, Jonigk D (2013) Epstein-Barr virus-associated smooth muscle tumours after transplantation, infection with human immunodeficiency virus and congenital immunodeficiency syndromes. Pathobiology 80:297–301

3. Stubbins R, AlamiLarussi N, Peters A, Urschel S, Dicke F, Lai R, Zhu J, Mabilangan C, Preiksaitis J (2019) Epstein-Barr virus associated smooth muscle tumours in solid organ transplant recipients: incidence over 31 years at a single institution and review of the literature. Transplant Infect Dis 21:e13010. https://doi.org/10.1111/tid.13010

4. Watanabe R, Schafernak KT, Soares FA (2023) EBV-associated smooth muscle tumour. In soft tissue and bone tumours. WHO classification of tumours, 5th edition, pp 190–192

5. Ong KW, Teo M, Lee V et al (2009) Expression of EBV latent antigens, mammalian target of rapamycin, and tumour suppression genes in EBV-positive smooth muscle tumours: clinical and therapeutic implications. Clin Cancer Res 15:5350–5358